World
Wall Street Responds to Retail Updates and Oil Prices
In a mixed morning session on Friday, stocks showed resilience, largely building on the solid gains witnessed throughout the week. Wall Street’s attention was divided...
Oil Prices Plunge as US Inventories Surge, Sparking Global Market Concerns
In a significant downturn on Wednesday, oil prices plummeted in response to a surge in US inventories, exacerbating concerns in the market about weakening demand...
Oil Prices Surge as US Inflation Data Misses Expectations
In a dramatic turn of events on Monday, oil prices experienced a significant uptick following the release of US inflation data that fell short of...
Meat Industry Dynamics Altered by Soaring Beef Imports
In a dramatic shift for the United States meat industry, record levels of beef imports are sweeping the nation as cattle herd numbers plummet to...
Airgain Q3 Results: Stock Plummets 37% After Revenue Drop
Airgain Inc, a prominent provider of wireless connectivity solutions, announced its financial results for the third quarter (Q3) ended September 30, 2023, triggering a significant...
OPEC Meeting on the Horizon: Oil Prices Rise Briefly, but Dark Clouds Linger
On Friday, oil prices experienced an increase, but they are poised to decline for the third consecutive week. This downturn in oil prices is attributed...
Oil Prices Plummet to 3-Month Low Amid Concerns of Weakening Demand in US and China
Oil prices reached a 3-month low on Wednesday, experiencing a sharp decline of over $1. This marks their lowest point since late July. The slump...
Kaixin Auto Holdings Reports 2023 Half-Year Unaudited Results, Stock Declines
On November 3, Kaixin Auto Holdings, a prominent new energy vehicle manufacturer and a leading platform for premium imported and used cars in China, unveiled...
BAIYU Holdings’ Stock Jumps 46% Post Financial Restructuring
In a strategic move aimed at reshaping its financial structure, BAIYU Holdings, a leading commodities trading service and provider based in China, announced on October...
Senti Biosciences Partners with Celest Therapeutics for Clinical Development of SENTI-301A in China, Stock Skyrockets Over 100%
In a strategic move aimed at advancing cancer treatment in China, Senti Biosciences has entered into a collaboration with Celest Therapeutics (Shanghai) Co Ltd, a...
